LINCOLN PHARMACEUTICALS LTD. - 531633 - Appointment of Company Secretary and Compliance Officer
Appointment of Ms. Trusha Shah (Membership No:A59416) as the Company Secretary & Compliance Officer at the Board Meeting held on 10.11.2022.10-11-2022
10-11-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On 30.09.2022
Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended on 30.09.202210-11-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Board Meeting Outcome for Outcome Of Board Meeting Held On 10.11.2022
Outcome of the Board Meeting to approve Unaudited Standalone & Consolidated Financial Results for the Quarter and half year ended on 30.09.202210-11-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Board Meeting Intimation for Board Meeting To Consider And Approve Un-Audited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2022. Other Business If Any.
LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 ,inter alia, to consider and approve Board meeting to consider and approve Un-audited financial Results (standalone and Consolidated) for the quarter and half year ended September 30, 2022. other business if any.31-10-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Minutes Of The 28Th Annual General Meeting
Minutes of the 28th Annual General Meeting14-10-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MAHENDRA PATELDesignation :- Managing Director / Whole Time Director14-10-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulation,201806-10-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Submission Of Voting Results Of 28Th A.G.M. Along With The Scrutinizes Report As Per Regulation 44 Of SEBI (LODR) Regulation 2015, As Amended.
Submission of Voting Results of 28th A.G.M. along with the Scrutinizes Report as per Regulation 44 of SEBI (LODR) Regulation 2015, as amended.01-10-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding of the 28th Annual General Meeting of The Company-Regulation 30 of SEBI (LODR) Regulation,201530-09-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30(LODR)-Newspaper publication07-09-2022